A trial led by Professor Chris Buckley, Kennedy Professor of Translational Rheumatology at the Universities of Oxford and Birmingham, has explored the effectiveness of otilimab in the treatment of rheumatoid arthritis. Read more here....

Professor Chris Buckley and Dr Adam Croft at the University of Birmingham’s Rheumatology Research Group have identified the chemical messenger which instructs cells to destroy joints, leading to hope for new treatments. Read the full article here....